Identification of extensive genomic loss and gain by comparative genomic hybridisation in malignant astrocytoma in children and young adults

Genes Chromosomes and Cancer

Volumn 31, Issue 1, 2001, Pages 15-22

  Warr, Tracy ^a,c   Ward, Samantha ^a   Burrows, Jenny ^a   Harding, Brian ^b   Wilkins, Peter ^b   Harkness, William ^c   Hayward, Richard ^a   Darling, John ^b   Thomas, David ^c  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

^b GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^c ATKINSON MORLEY S HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; ASTROCYTOMA; CHILD; CHROMOSOME 12Q; CHROMOSOME 13; CHROMOSOME 16P; CHROMOSOME 17P; CHROMOSOME 22; CHROMOSOME 2Q; CHROMOSOME 4Q; CHROMOSOME 5Q; CHROMOSOME 8Q; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; FLUORESCENCE; GROUPS BY AGE; HUMAN; MALE; NUMERICAL CHROMOSOME ABERRATION; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ASTROCYTOMA; CENTRAL NERVOUS SYSTEM NEOPLASMS; CHILD; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; FEMALE; GENE AMPLIFICATION; GENE DOSAGE; HUMANS; IN SITU HYBRIDIZATION; MALE; SEQUENCE DELETION;

EID: 0035057171     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.1113     Document Type: Article

References (55)

1. Cytogenetic analysis of 120 primary pediatric brain tumors and literature review
2. Chromosomal evolution in malignant human gliomas starts with specific and usually numerical deviations
3. Chromosomal characteristics of childhood brain tumours
4. Microsatellite analysis of childhood brain tumours
5. Mutation of the PTEN (MMAC1) tumor suppressor gene in a subset of glioblastomas but not in meningiomas with loss of chromosome arm 10q
6. PTEN mutations in gliomas and glioneuronal tumors
7. Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Children's Cancer Group
8. Chromosome analysis of brain tumours in childhood
9. Loss of heterozygosity on chromosome 16p13.3 in hamartomas from tuberous sclerosis patients
10. Chromosome abnormalities in pediatric brain tumours
11. The retinoblastoma gene is involved in malignant progression of astrocytomas
12. Association of loss of heterozygosity on chromosome 17p with high platelet-derived growth factor alpha receptor expression in human malignant gliomas
13. Common regions of deletion on chromosome 22q12.3-q13.1 and 22q13.2 in human astrocytomas appear related to malignancy grade
14. Genetic aberrations detected by comparative genomic hybridisation in archival paraffin-embedded tumour samples
15. Deletion of p16 and p15 genes in brain tumors
16. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors
17. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization
18. Loss of heterozygosity in malignant gliomas involves at least three distinct regions on chromosome 10
19. Cytogenetic analysis of 39 pediatric central nervous system tumours
20. The new WHO classification of brain tumours
21. Structural and functional evidence for the presence of tumour suppressor genes on the short arm of chromosome 10 in human gliomas
22. High frequency of p53 protein accumulation without p53 gene mutation in human juvenile pilocytic, low grade and anaplastic astrocytoma
23. Pathways leading to glioblastoma multiforme: A molecular analysis of genetic alterations in 65 astrocytic tumors
24. Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report
25. Childhood brain tumours in vitro: Chemosensitivity of short-term cultures in vitro correlates with clinical sensitivity
26. The lack of a role for p53 in astrocytomas in pediatric patients
27. The p53 gene and protein in human brain tumors
28. Molecular genetics of pediatric brain stem gliomas: Application of PCR techniques to small and archival brain tumour specimens
29. Malignant astrocytic gliomas in children
30. Genetic analysis of glioblastoma multiforme provides evidence for subgroups within the grade
31. DMBT1, a new member of the SRCR superfamily, on chromosome 10q25.3-26.1 is deleted in malignant brain tumours
32. Frequent expression of a mutant epidermal growth factor receptor in multiple human tumors
33. Cytogenetic analysis of 109 pediatric central nervous system tumors
34. Investigation of genetic alterations associated with the grade of astrocytic tumor by comparative genomic hybridization
35. Pediatric brain tumours: Loss of heterozygosity at 17p and TP53 gene mutations
36. A region of common deletion in 22q13.3 in human glioma associated with astrocytoma progression
37. The relationship between TP53 mutations and overexpression of p53 and prognosis in malignant gliomas of childhood
38. Alterations of the TP53 gene in human gliomas
39. Refined mapping of 12q13-q15 amplicons in human malignant gliomas suggests CDK4/SAS and MDM2 as independent amplification targets
40. Loss of heterozygosity for distal markers on 22q in human gliomas
41. Abnormalities of chromosome 22 in human brain tumours determined by combined cytogenetic and molecular genetic approaches
42. Refined deletion mapping of the chromosome 19q glioma tumor suppressor gene to the D19S412-STD interval
43. Cytogenetics of pediatric central nervous system tumors
44. Comparative genomic hybridization of human malignant gliomas reveals multiple amplification sites and nonrandom chromosomal gains and losses
45. Subependymal giant cell astrocytoma: A clinical, pathological and flow cytometric study
46. Localization of common deletion regions on 1p and 19q in human gliomas and their association with histological subtype
47. Karyotypes in 90 human gliomas
48. Cytogenetic studies in 45 pediatric brain tumors
49. Association of epidermal growth factor receptor gene amplification with loss of chromosome 10 in human glioblastoma multiforme
50. Evidence for a tumor suppressor gene on chromosome 19q associated with human astrocytomas, oligodendrogliomas, and mixed gliomas
51. Loci associated with malignant progression in astrocytomas: A candidate on chromosome 19q
52. Characterization of genomic alterations associated with glioma progression by comparative genomic hybridization
53. MXI1, a putative tumor suppressor gene, suppresses growth of human glioblastoma cells
54. Deletion of chromosome 17p DNA sequences in pediatric high-grade and juvenile pilocytoc astrocytomas